Lusutrombopag
id:
lusutrombopag-272-9344698
title:
Lusutrombopag
text:
Lusutrombopag, sold under the brand name Mulpleta among others, is a medication that has been developed for certain conditions that lead to thrombocytopenia such as thrombocytopenia associated with chronic liver disease in patients prior to elective invasive procedures. It is being manufactured and marketed in Japan by Shionogi. It was approved by the U.S. Food and Drug Administration (FDA) in July 2018, and NICE in January 2020. It was approved for medical use in the European Union in February
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Lusutrombopag
date created:
date modified:
2023-04-03T23:50:09Z
main entity:
{"identifier":"Q27265116","url":"https://www.wikidata.org/entity/Q27265116"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/07/Lusutrombopag.svg","width":1215,"height":465}
fields total:
13
integrity:
15